Texas
LATEST FROM BIOSPACE
With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the “winners and losers” from the conference.
A look at whether big money and big deals will be in store for 2018.
A look at the latest startups that have emerged in 2018 so far.
Here are some thoughts on breaking into the biomechanical engineering market.
A look at some of the superstitions and rituals that scientists apply to their work.
The deal is expected to close in the first quarter of 2018.
It’s no secret that the life sciences are increasingly international.
Here are five trends job hunters may see in the life sciences next year.
A look at the 19 spine-related medical devices the FDA cleared in October.
Mr. Hartman overviewed the Company’s Anti-Cancer R&D program and discussed his intent to find a licensee for the technology or investment partner to complete the development of this very promising anti-cancer antibody drug.
PRESS RELEASES